Thank you, Mr. Chair.
Speaking of written documentation, I'm wondering whether or not it would be possible for our witnesses to provide a list of all government meetings with the pharmaceutical lobby and related companies since the beginning of the pandemic, including notes from those meetings, if possible.
My question is going to follow up on my colleague Mr. Bergeron's questions on ODA.
My concern is that if ODA is being calculated using vaccines as part of our official development assistance, we will not see the same levels in other areas. If we calculate these as part of our ODA, will there be an impact on other areas where ODA is vitally important as we recover from COVID-19?
Mr. Tabah, perhaps you could take that one.